This page contains brief information about trabectedin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Use in Cancer
Trabectedin is approved to treat:
- Liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or have metastasized (spread to other parts of the body). It is used in patients who have already been treated with anthracyclinechemotherapy.
Trabectedin is also being studied in the treatment of other types of cancer.
More About Trabectedin
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trials Accepting Patients
Find Clinical Trials for Trabectedin - Check for trials from NCI's list of cancer clinical trials now accepting patients.
No hay comentarios:
Publicar un comentario